Keyword: CU Chemie Uetikon

News

Ardian in Talks for Sale of Novacap Stake

24.03.2016 - French private equity fund Ardian has started talks with two buy-out firms for the sale of its majority stake in chemicals and pharmaceuticals producer Novacap. The firm is in...

News

CU Chemie Uetikon Sold to Novacap

12.05.2015 - Private equity investor Equistone Partners Europe has sold its majority shareholding in German fine chemicals and pharmaceutical ingredients manufacturer CU Chemie Uetikon for an...

News

Thomas Seeler New Managing Director of CU Chemie Uetikon

30.01.2013 - The long-standing CEO of CU Chemie Uetikon, Heinz Sieger (65) will move to the company's Supervisory Board effective 1 February, where he will assume the chairmanship. Thomas...

Chemistry & Life Sciences

Chemical Industry’s Expectations for the U.S. Business Climate in 2013

29.01.2013 - A Look into the Future - Where is the U.S. economy heading in 2013? Industry leaders predict their companies will navigate uncertainty, including changes in pharmaceutical...

News

Pharma outsourcing

25.09.2012 - CHEManager Europe asked experts from the pharmaceutical ingredients and custom synthesis industry to share their opinions on this topic prior to the industry global networking...

News

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

28.10.2011 - Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany. With a shareholding of 90%, BPE will have...

In Conversation with Dr. Heinz Sieger, CEO of CU Chemie Uetikon

21.06.2011 - CU Chemie Uetikon CEO Heinz Sieger spoke to CHEManager Europe Editor Brandi Schuster about what his customers are looking for when it comes to custom synthesis. Sieger is also...

News

Time For Action

07.05.2010 - The German advertising tagline "greed is good" is now outmoded as a basic principle of purchasing. A low purchase price does not mean that a product is actually inexpensive...